Fixed Dose Disposable Pen For Enoxaparin HGH Peptide

Product description

Fixed-dose disposable mechanical syringe, the syringe is original mechanical transmission, hand-press injection, the injection dose is fixed.

Product Features
①It is suitable for 3mL cartridge bottle conforming to ISO 11608-3 standard, and suitable for disposable injection pen needle conforming to ISO 11608-2 standard.
②The dose is fixed at 0.06mL, and the dose accuracy is in line with the international ISO 11608-1 standard.
③ Independent patented transmission technology, direct push medicine, safe and reliable.
④Super large dose display, with good readability, also suitable for patients with impaired vision.
⑤The dosage setting and correction operation is simple, and the patient's operability is good.

Test report number
QX2021B00308

Application

It is suitable for short-term and long-term injection treatment of fixed-dose biomedicine such as teriparatide and insulin.

Jiangsu Delfu medical device Co.,Ltd(Delfu Medical), is an innovative leading Chinese manufacturer and supplier, engages in research, manufacturing, marketing and sales medical devices, offers diagnosis, analysis, monitoring and treatment medical equipments for diabetes and cardiac patients. We focus on products of series Insulin injection pen, insulin pumps, continuous glucose monitoring systems, personal wireless real-time ECG monitors, etc. Especially we have made the name of injection pen with its full series and unique design in China, including electronic syringe, auto pen, smart insulin pen, prefilled insulin pen, needle hidden HGH injection pen, metal and plastic manual injection pen.

Delfu Medical brings the revolutionary technology for its continuous developing, with its 20 years supplying quality products,credibility and efficient services, has been recognized and trusted by domestic and international clients. Covers around 800,000 floor areas totally in two manufacturing locations with advanced facilities and equipment. We keep 20%~30% growing by bringing credit to management, staff and our products.

Delfu Medical cooperates with 5 China top-ranking universities, including Nanjing University, South-East University in regard to product research and support for sustainable development. we hold intellectual property rights of 6 invention patents and a number of utility patents.

Delfu Medical is looking for oversea medical devices partner of pharmaceutical manufacturer, distributors, traders and agents, which is diabetic and cardiac patients product related. We also welcome OEM/ODM cooperation and solution for any unique and beneficial product.

Delfu Medical upholds the mission of improving life quality of diabetes and cardiac patients, exercises and affords the utmost social responsibility at all time, provides most safe, reliable, high- performance medical devices at competitive prices. we are committed to help world wide clients develop profitable relationships from China.